butyric acid and panobinostat

butyric acid has been researched along with panobinostat in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Alfano, AI; Barone, S; Brindisi, M; Cassese, E; Summa, V1
Cho, JH; Dimri, GP; Dimri, M1
Chen, K; Guo, Y; Jia, X; Zheng, Y1
Fukuda, H; Harada, M; Hayakawa, A; Kominato, Y; Kubo, R; Okawa, T; Sano, R; Takahashi, Y1

Reviews

1 review(s) available for butyric acid and panobinostat

ArticleYear
Chasing a Breath of Fresh Air in Cystic Fibrosis (CF): Therapeutic Potential of Selective HDAC6 Inhibitors to Tackle Multiple Pathways in CF Pathophysiology.
    Journal of medicinal chemistry, 2022, 02-24, Volume: 65, Issue:4

    Topics: Animals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Histone Deacetylase 6; Humans; Signal Transduction

2022

Other Studies

3 other study(ies) available for butyric acid and panobinostat

ArticleYear
MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence.
    The Journal of biological chemistry, 2015, Apr-17, Volume: 290, Issue:16

    Topics: Apoptosis; Butyric Acid; Cell Line, Tumor; Cellular Senescence; Feedback, Physiological; Female; Gene Expression Regulation, Neoplastic; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; MCF-7 Cells; Microarray Analysis; MicroRNAs; Oligonucleotide Array Sequence Analysis; Panobinostat; Polycomb Repressive Complex 1; Signal Transduction; Transcription, Genetic

2015
Sodium butyrate and panobinostat induce apoptosis of chronic myeloid leukemia cells via multiple pathways.
    Molecular genetics & genomic medicine, 2019, Volume: 7, Issue:5

    Topics: Antineoplastic Agents; Apoptosis; Butyric Acid; Cell Line, Tumor; Drug Resistance, Neoplasm; Endoplasmic Reticulum Stress; Histone Deacetylase Inhibitors; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Panobinostat

2019
Histone deacetylase inhibitors suppress ACE2 and ABO simultaneously, suggesting a preventive potential against COVID-19.
    Scientific reports, 2021, 02-09, Volume: 11, Issue:1

    Topics: ABO Blood-Group System; Angiotensin-Converting Enzyme 2; Butyric Acid; Cell Line; COVID-19; COVID-19 Drug Treatment; Epithelial Cells; Gene Expression Regulation; Histone Deacetylase Inhibitors; Humans; Panobinostat; Serine Endopeptidases

2021